Citation Impact
Citing Papers
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
2017 Standout
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Patient‐reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T‐DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2–positive locally advanced or metastatic breast cancer
2013
Head and neck squamous cell carcinoma
2020 Standout
The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2−negative metastatic breast cancer: experience from the patient perspective
2014
Cytokines in inflammatory bowel disease
2014 Standout
A new taxonomy for describing and defining adherence to medications
2012 Standout
A review of economic impact of targeted oral anticancer medications
2013
It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.
2011
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
2012
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit
2007
NF-κB signaling in inflammation
2017 Standout
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2016 Standout
Report of the NIH Task Force on Research Standards for Chronic Low Back Pain
2014
The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
2015
Estimates of Pain Prevalence and Severity in Adults: United States, 2012
2015 Standout
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
2013
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Oral Cancer and Precancerous Lesions
2002 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
2012
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
2017
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
2010
Inflammation and Bone Destruction in Arthritis: Synergistic Activity of Immune and Mesenchymal Cells in Joints
2012
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
2011
The microbiome and rheumatoid arthritis
2011
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
2013
Patient Preferences and Linear Scoring Rules for Patient-Reported Outcomes
2010
Assessment of preferences for treatment: Validation of a measure
2009
Ulcerative colitis
2016 Standout
Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
2011 Standout
Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires
2005
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis
2020
Head and Neck Cancer
1993 Standout
Report of the NIH Task Force on Research Standards for Chronic Low Back Pain
2014
Rheumatoid arthritis
2010 Standout
Functional Specialization of Interleukin-17 Family Members
2011 Standout
A Meta-analysis of Alcohol Drinking and Oral and Pharyngeal Cancers: Results from Subgroup Analyses
2012
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
2007
Evaluation of an end-tidal carbon dioxide detector in the aeromedical setting
1990
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Medication Adherence: WHO Cares?
2011 Standout
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain
2013
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
2015
Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling
2010
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
2012
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
2010
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
2009 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Review article: novel oral‐targeted therapies in inflammatory bowel disease
2018
Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
2013
Smoking and drinking in relation to oral and pharyngeal cancer.
1988 Standout
Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
2019
The effects of prescription drug copayments on statin adherence.
2006
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
2015
Clinically Important Changes in Short Form 36 Health Survey Scales for Use in Rheumatoid Arthritis Clinical Trials: The Impact of Low Responsiveness
2014
Self-Reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications
2004
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016
2018 Standout
Snuff Dipping and Oral Cancer among Women in the Southern United States
1981
Selective JAK inhibitors in development for rheumatoid arthritis
2014
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Natural product and natural product derived drugs in clinical trials
2014 Standout
Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx
1984
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates
1991
A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis
2014
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
2016 StandoutNobel
Prevalence of chronic low back pain: systematic review
2015 Standout
Medication Adherence
2009 Standout
Medication Adherence Measures: An Overview
2015 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Report of the NIH Task Force on research standards for chronic low back pain.
2015
Industry sponsorship and research outcome
2017 Standout
What are validated self-report adherence scales really measuring?: a systematic review
2013
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
2011
Baricitinib for the treatment of rheumatoid arthritis
2016
Factors affecting therapeutic compliance: A review from the patient’s perspective
2008 Standout
Works of John Coombs being referenced
Preliminary development of a responder index for chronic low back pain.
2007
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial
2009
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo
2009
Are Chemotherapy Patients’ HRQoL Importance Weights Consistent with Linear Scoring Rules? A Stated-choice Approach
2006
Development of the Cancer Therapy Satisfaction Questionnaire: Item Generation and Content Validity Testing
2005
Budgetary Impact of Treatment with Adjuvant Imatinib for 1 Year Following Surgical Resection of Kit-Positive Localized Gastrointestinal Stromal Tumors
2010
Stated Preferences of Patients with Cancer for Health-related Quality-of-life (HRQOL) Domains During Treatment
2006
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
2009
Compliance from Self-Reported versus Pharmacy Claims Data with Metered-Dose Inhalers
2001
Compliance and refill pattern behavior with HMG-CoA reductase inhibitors after acute myocardial infarction.
2002
Unexplained Hepatitis following Halothane: Case Report
1980
Early Onset of Oral Cancer among Women who Drink and Smoke
1976